The activation of the AhR induced by coronaviruses leads to the up-regulation of downstream AhR elements, resulting in the manifestation of “Systemic AhR Activation Syndrome” (SAAS), which includes symptoms such as inflammation, fibrosis, thromboembolism, and potentially multiple organ dysfunction syndrome or mortality (20). The gene discussed is AHR; the disease is Thromboembolism.